EICHOR
● Recruiting
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
Condition: Lymphoma, Non-Hodgkin · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to determine the putative recommended Phase 2 doses (RP2Ds) and optimal dose schedule(s) for JNJ-95566692 as a single agent (Arm A) and in combination with JNJ-87801493 (Arm B) (Part 1: Dose Escalation) and to further characterize the safety and clinical activity of JNJ-95566692 as a single agent (Arm A) and in combination with JNJ-87801493 (Arm B) at the putative RP2D(s) (Part 2: Dose Expansion).
This description comes directly from the study's public registry record.
Talk to the study team
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
Locations (19)
| Monash Medical Centre | Clayton, Australia | Recruiting |
| Peter MacCallum Cancer Centre | Melbourne, Australia | Recruiting |
| Macquarie University Hospital | North Ryde, Australia | Recruiting |
| Scientia Clinical Research | Randwick, Australia | Recruiting |
| UZ Antwerpen | Edegem, Belgium | Recruiting |
| Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman | Liège, Belgium | Recruiting |
| Hopital Claude Huriez | Lille, France | Recruiting |
| CHU Pitie Salpetriere | Paris, France | Recruiting |
| CHU Lyon Sud | Pierre-Bénite, France | Recruiting |
| Institut Universitaire du Cancer Toulouse Oncopole | Toulouse, France | Recruiting |
| Hosp Univ Vall D Hebron | Barcelona, Spain | Recruiting |
| Hosp. Clinic de Barcelona | Barcelona, Spain | Recruiting |
+ 7 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07308132